Physician profile
Marilyn Ryan
NPI 1386733780
$2,070.75
in general payments reported to CMS, 2019-2025
20 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $50.89 · 2021: $214 · 2022: $277 · 2023: $363 · 2024: $416 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $804.45 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $281.37 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $256.19 | 2019-2022 | |
| Abbott Laboratories | $152.85 | 2022-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $74.60 | 2022-2025 | Minimed 780g |
| Abbvie INC. | $74.16 | 2019-2023 | Synthroid |
| Astrazeneca Pharmaceuticals LP | $67.36 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.51 | 2022-2025 | |
| Bigfoot Biomedical INC | $47.07 | 2021-2022 | |
| Beta Bionics, INC. | $41.38 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Xeris Pharmaceuticals, INC. | $35.69 | 2021-2024 | Gvoke Hypopen |
| Ibsa Pharma INC. | $26.21 | 2020-2021 | |
| Amgen INC. | $23.90 | 2019 | |
| Glaxosmithkline, LLC. | $21.74 | 2025 | Shingrix, Arexvy |
| Sequel Med Tech, LLC | $21.44 | 2025 | Twiist |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.65 | 2024 | Jardiance |
| Intuity Medical INC | $17.64 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ucb, INC. | $15.90 | 2019 | |
| Insulet Corporation | $13.57 | 2024 | Omnipod |
| Valeritas, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.